BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18978173)

  • 1. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P
    Gut; 2009 Feb; 58(2):182-8. PubMed ID: 18978173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.
    Zaninotto G; Minnei F; Guirroli E; Ceolin M; Battaglia G; Bellumat A; Betetto G; Bozzola L; Cassaro M; Cataudella G; Dal Bò N; Farinati F; Florea G; Furlanetto A; Galliani E; Germanà B; Guerini A; Macrì E; Marcon V; Mastropaolo G; Meggio A; Miori G; Morelli L; Murer B; Norberto L; Togni R; Valiante F; Rugge M
    Dig Liver Dis; 2007 Jan; 39(1):18-25. PubMed ID: 17141593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
    Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
    Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
    Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
    Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
    Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study.
    Erichsen R; Horvath-Puho E; Lund JL; Dellon ES; Shaheen NJ; Pedersen L; Davey Smith G; Sørensen HT
    Aliment Pharmacol Ther; 2017 Apr; 45(7):973-982. PubMed ID: 28139003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of Barrett's oesophagus: a population-based study.
    Coleman HG; Bhat S; Murray LJ; McManus D; Gavin AT; Johnston BT
    Eur J Epidemiol; 2011 Sep; 26(9):739-45. PubMed ID: 21671079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy.
    Abrams JA; Fields S; Lightdale CJ; Neugut AI
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):30-4. PubMed ID: 18063419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin and the risk of Barrett's oesophagus.
    Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
    Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and regional variations of patients with Barrett's oesophagus in the UK.
    Caygill CP; Watson A; Reed PI; Hill MJ;
    Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1217-22. PubMed ID: 14560156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta analysis: Cancer risk in Barrett's oesophagus.
    Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
    Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
    Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.